Articles On LBT Innovations (ASX:LBT)

Title Source Codes Date
LBT Innovations (ASX:LBT) partners with AstraZeneca for APAS Pharma development

LBT Innovations (LBT) pens a deal with AstraZeneca to undertake full product development of its APAS Pharma artificial intelligence software The APAS Pharma analysis module will be developed to identify microbial growth on settle plates...

themarketherald.com.au LBT 2 years ago
Overnight signs that US inflation is easing: Aus shares 1% higher at noon

ShareCafeOvernight signs that US inflation is easing: Aus shares 1% higher at noon by Peter Milios   At noon, all sectors across the ASX are higher, after the release of the December jobs report data, as well as an economic activity survey....

ShareCafe LBT 2 years ago
Stocks of the Hour: LBT, ESS, SBR

ShareCafeStocks of the Hour: LBT, ESS, SBR                    LBT Innovations (ASX:LBT) has been engaged by AstraZeneca to undertake a full product development project for LBT’s new APAS Pharma analysis module, which will be used on t...

ShareCafe LBT 2 years ago
ASX Health Stocks: LBT Innovations picked by AstraZeneca as partner, share price surges 22pc

LBT Innovati0ns engaged by global pharma company, AstraZeneca Volpara nabs $7m plus contracts Imugene receives ethics approval for Vaxinia   LBT to partner with AstraZeneca LBT Innovations (ASX:LBT) surged 22%% this morning after announci...

Stockhead LBT 2 years ago
Stocks of the Hour: LBT Innovations, Essential Metals, Sabre Resources

09 Jan 2023 - A snapshot of the stocks on the move, featuring LBT Innovations, Essential Metals and Sabre Resources.

FNN LBT 2 years ago
LBT Innovations to partner with AstraZeneca on development of APAS Pharma microbial monitoring product

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Australian medical technology company LBT Innovations (ASX: LBT) will partner with global biopharmaceutical firm AstraZeneca for the full product development of its AP...

SmallCaps LBT 2 years ago
Top 10 at 10: These ASX lithium and helium stocks are looking monstrous on Monday morning

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead LBT 2 years ago
CLOSING BELL: Because it’s time to go home when the ferris wheel breaks

ASX takes a pre-Christmas bath, dragged down by InfoTech and Discretionary Asian markets fall lower today as Japan widens yield target range PolarX is still ruling the playground after one of the big kids said it was cool With apologies t...

Stockhead LBT 2 years ago
Stocks of the Hour: Avecho Biotechnology, LBT Innovations, Meteoric Resources

20 Dec 2022 - A snapshot of the stocks on the move featuring Avecho Biotechnology (ASX:AVE), LBT Innovations (ASX:LBT) and Meteoric Resources (ASX:MEI).

FNN LBT 2 years ago
LBT Innovations subsidiary appoints APAS Independence distributor for Europe

Australian medical technology company LBT Innovations (ASX:LBT) has announced the appointment of Thermo Fisher Scientific as the exclusive distributor for the APAS Independence in Europe.

BiotechDispatch LBT 2 years ago
LBT Innovations (ASX:LBT) appoints Thermo Fisher as European distributor of APAS Independence

LBT Innovations (LBT) appoints Thermo Fisher Scientific as its exclusive distributor for the APAS Independence product in EuropeThe move expands LBT’s existing distribution agreement for the APAS Independence to include up to 35 countries g...

themarketherald.com.au LBT 2 years ago
Oil falls to lowest price since 2021: ASX closes 0.42% lower

ShareCafeOil falls to lowest price since 2021: ASX closes 0.42% lower by Peter Milios   Amidst the ongoing tensions arising from the continuation of China’s lockdowns from their recent COVID surge, oil has fallen to its lowest point since D...

ShareCafe LBT 3 years ago
China’s lockdown rampage causes lower start to ASX

ShareCafeChina’s lockdown rampage causes lower start to ASX by Peter Milios   China’s persistent lockdowns have caused commodity prices and futures to fall. As a result, at noon, the S&P/ASX 200 is 0.34 per cent or 24.50 points lower at...

ShareCafe LBT 3 years ago
How out of favour Biotech has a PR problem and could learn from Dr Karl

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

Stockhead LBT 3 years ago
Top 10 at 10: These ASX rare earths, lithium and green hydrogen stocks are thrilling punters today

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead LBT 3 years ago
Closing Bell: Sezzle’s got some zip, Zip’s got some sizzle and Openpay’s TTV jumps 50%

ASX200 and small caps end about 0.4% down BNPLs come out of hibernation WA1 is finding even more niobium   Local markets failed to launch on Wednesday, unlike the missile strikes early this morning AEDT, which reportedly crossed the borde...

Stockhead LBT 3 years ago
Webinar Recap – EMH, MCL, WML & LBT

ShareCafeWebinar Recap – EMH, MCL, WML & LBT Catch up on the full webinar presentations from European Metals (ASX: EMH), Mighty Craft (ASX: MCL), Woomera Mining (ASX: WML) & LBT Innovations (ASX: LBT) Webinar Recap – EMH, MCL, WML...

ShareCafe LBT 3 years ago
LBT Innovations (ASX: LBT) – Webinar Presentation

ShareCafeLBT Innovations (ASX: LBT) – Webinar Presentation Brent Barnes – Managing Director & CEO – LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry. LBT Innovations (ASX: LBT) – We...

ShareCafe LBT 3 years ago
Top 10 at 10: ASX rare earths and lithium stocks dominate at the open, once again

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead LBT 3 years ago
Strong finish despite tomorrow’s expected rate hike: ASX closes 1.15% higher

ShareCafeStrong finish despite tomorrow’s expected rate hike: ASX closes 1.15% higher by Peter Milios   All eyes are on tomorrow’s expected interest rate hike, with many predicting a 50 basis point rise. To finish the day the S&P/ASX 20...

ShareCafe LBT 3 years ago
IT sector rallies to lift the market: ASX up 0.94% at noon

ShareCafeIT sector rallies to lift the market: ASX up 0.94% at noon The local market has commenced the week in the green with the S&P/ASX 200 up 0.94 per cent or 63.70 points higher to 6,849.40 at noon. This comes off the back of US equ...

ShareCafe LBT 3 years ago
Energy and Materials only sectors left lagging: ASX closes 0.28% higher

ShareCafeEnergy and Materials only sectors left lagging: ASX closes 0.28% higher by Peter Milios   In today’s events, independent commission agency ASIC has launched legal action against BPS Financial, the company behind Gold Coast-based di...

ShareCafe LBT 3 years ago
Closing Bell: C29 goes interstellar on Argentine-brine; Benchmark stays afloat on light volumes ahead of Budget and CPI

The ASX 200 trims gains to end circa 0.3% higher Small caps drop 0.2%, but C29 Metals booms China markets still choppy after political appointments   The big show, if balancing books and picking pre-chosen soundbytes is your thing, begins...

Stockhead LBT 3 years ago
Optimism out of the US boosts sentiment: ASX up 0.6% at noon

ShareCafeOptimism out of the US boosts sentiment: ASX up 0.6% at noon by Lauren Hayes   Positive gains in the local market have extended into a second day as optimism out of the US about corporate earnings ahead of several key tech reports...

ShareCafe LBT 3 years ago
IT and Materials lead the way: ASX finishes 1.54% higher

ShareCafeIT and Materials lead the way: ASX finishes 1.54% higher by Peter Milios   All sectors finished in the green to start the week, with some big results from Australian electric vehicle companies. The ASX companies that were amongst t...

ShareCafe LBT 3 years ago
Monday morning rally: ASX up 1.73% at lunch

ShareCafeMonday morning rally: ASX up 1.73% at lunch by Lauren Hayes   The Australian market is enjoying a solid start to the trading week after US equities snapped their two-day losing streak and posted solid gains on more strong corporate...

ShareCafe LBT 3 years ago
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

Stockhead LBT 3 years ago
LBT Innovations (ASX: LBT) Developing Clean-Room Technology for Pharma Companies

ShareCafeLBT Innovations (ASX: LBT) Developing Clean-Room Technology for Pharma Companies LBT Innovations Limited (ASX: LBT) CEO and Managing Director Brent Barnes discusses new opportunities for the company’s automation technology. LBT In...

ShareCafe LBT 3 years ago
ScoPo’s Powerplays: Taps on again with ASX health stocks in BIG capital raises

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. Several ASX health stocks have...

Stockhead LBT 3 years ago
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Stockhead LBT 3 years ago
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Stockhead LBT 3 years ago
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

Stockhead LBT 3 years ago
Dr Boreham’s Crucible: With sales success, does LBT have the world on a plate?

For most medical device companies, selling six instruments within the space of six months would hardly be cause for celebration. But for the Adelaide-based LBT Innovations (ASX:LBT), the sales “inflexion point” was an excuse to crack open a...

Stockhead LBT 3 years ago
ScoPo’s Powerplays: Health stocks tumble but half-price sale presents buying opportunities

Healthcare and life sciences expert Scott Power – a senior analyst with Morgans Financial for 24 years – on what the movers and shakers have been doing in health and which ASX health stocks make Scott’s Powerplays. Are you the cuddly type?...

Stockhead LBT 3 years ago
Closing Bell: Interest piqued? Not for sliding local markets on Rates Day

The interest rate rise came and the markets fell, then turned a corner. The question now is — will the wheels stay on? Already lagging, the ASX Emerging Companies (XEC) index has closed 0.8% lower. The benchmark has closed 0.4% behind. The...

Stockhead LBT 3 years ago
Check Up: Money managers are still bullish on Healthcare; here’s what they said

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Stockhead LBT 3 years ago
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Stockhead LBT 3 years ago
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Stockhead LBT 3 years ago
ScoPo’s Powerplays: ‘We’ve gone from a boiled lolly to a prize-winning chocolate in the space of a week’

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. At the start of trade on Frida...

Stockhead LBT 3 years ago
Closing Bell: Any price is totally right

The ASX Emerging Companies Index (XEC) has ended 1.5% higher on Wednesday, driven by a new EV car as a few battery metal small caps locked in the right prices from a government ready to pay. The ASX200 has also risen a further 1.1% driven b...

Stockhead LBT 3 years ago
LBT Innovations (ASX:LBT) subsidiary CCS secures US order for APAS instruments

LBT Innovations’ (LBT) wholly owned subsidiary Clever Culture Systems (CCS) receives purchase orders for five APAS Independence instruments from its US-based distributor Thermo Fisher Scientific It comes after LBT acquired the remainder of...

themarketherald.com.au LBT 3 years ago
Check Up: The future of telehealth, and the best and worst performing ASX health stocks for the month

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Stockhead LBT 3 years ago
Check Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASX

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Stockhead LBT 3 years ago
Webinar Recap – TNR, LBT, 1AD & LIT

ShareCafeWebinar Recap – TNR, LBT, 1AD & LIT Catch up on the full webinar with presentations from Torian Resources (ASX: TNR), LBT Innovations (ASX: LBT),  Adalta (ASX: 1AD) & Lithium Australia (ASX: LIT) Webinar Recap – TNR...

ShareCafe LBT 3 years ago
LBT Innovations (ASX: LBT) – Webinar Presentation

ShareCafeLBT Innovations (ASX: LBT) – Webinar Presentation Brent Barnes – CEO & Managing Director – LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry. LBT Innovations (ASX: LBT) – We...

ShareCafe LBT 3 years ago
ScoPo’s Powerplays: For healthcare, a case of nerves ahead of reporting season

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week There’s so...

Stockhead LBT 3 years ago
LBT Innovations (ASX:LBT) completes CCS acquisition

LBT Innovations (LBT) completes the acquisition of Clever Culture Systems (CCS) and now owns 100 per cent On December 29, the company signed a binding agreement with Hettich to acquire its 50 per cent holding in CCS The acquisition consi...

themarketherald.com.au LBT 3 years ago
ASX Health Stocks: Imugene levels up in Phase 1 trial, Imricor slides into Greece

The ASX 200 Health Index (XHJ) is trading higher by 0.30% at the time of writing, compared to the broader index which is also up by 0.87%. Imugene (ASX:IMU) is up by 8% this morning, after confirming that its immunotherapy candidate, PD1-Va...

Stockhead LBT 3 years ago
10 at 10: These ASX stocks are finishing the year with a blinder of a day this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead LBT 3 years ago
Check Up: As Omicron rages, rapid antigen testing specialist Atomo surges nearly 50pc

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

Stockhead LBT 3 years ago